Singapore, Nov. 27 -- Hikma Pharmaceuticals PLC,the multinational pharmaceutical company, has signed an exclusive licensing agreement with DGI Group LLC, a US-based company specialising in professional and commercial medical equipment and supplies. The agreement grants Hikma exclusive rights to commercialise Claritag(R), an innovative, OTC skin tag removal device, across the Middle East and North Africa (MENA) region.

Claritag(R) is a quick and effective skin tag removal device featuring patented Squeeze & Freeze(R) technology, offering safe and effective at home treatment for adults 21 years and older. It uses an innovative treatment technique causing skin tags to fall off naturally within seven to fourteen days. The device is a leading...